MTA2 and metabolic dysfunction-associated steatohepatitis: In this review, methods for reporting results were restricted to individual genes; however, a novel method of reporting using PID pathways was utilised by Chen et al6 (not included in review), which may be useful to identify the molecular pathways involved in the development of NAFLD and progression to NASH.